发明名称 Acylaminoalkenylene-amide derivatives useful in treatments of the respiratory diseases where it is more specific for NK1 than NK2
摘要 A compound of formula described having valuable pharmaceutical properties and effective especially as NK1 (neurokinin-1) and NK2 antagonists. Wherein, R is phenyl that is unsubstituted or is substituted by 1, 2 or 3 substituents selected from the group halogen, C1-7alkyl, trifluoromethyl, hydroxy and lower alkoxy, R1 is hydrogen or C1-7alkyl, R2 is hydrogen, lower alkyl or phenyl that is unsubstituted or is substituted by 1, 2 or 3 substituents selected from the group halogen, C1-7alkyl, trifluoromethyl, hydroxy and lower alkoxy, R3 is phenyl that is unsubstituted or is substituted by 1, 2 or 3 substituents selected from the group halogen, C1-7alkyl, trifluoromethyl, hydroxy and lower alkoxy; or is naphthyl, 1H-indol-3-yl or 1-lower alkyl-indol-3-yl, R4' and R4" are each independently of the other hydrogen or C1-7alkyl, at least one of the radicals R4' and R4" being hydrogen, and R5 is C3-8cycloalkyl, D-azacycloheptan-2-on-3-yl or L-azacycloheptan-2-on-3-yl; or a salt thereof. The compound of the formula described is useful for in the prevention or treatment of diseases of the upper and lower respiratory tract, such as bronchial asthma, allergic asthma, non-allergic asthma, allergic hypersensitivity and hypersecretion conditions.
申请公布号 NZ334736(A) 申请公布日期 2000.09.29
申请号 NZ19970334736 申请日期 1997.08.13
申请人 NOVARTIS AG 发明人 GERSPACHER, MARC;VON SPRECHER, ANDREAS;MAH, ROBERT;ROGGO, SILVIO;STUTZ, STEFAN
分类号 C07D223/10;A61K31/165;A61K31/40;A61K31/404;A61K31/55;A61P1/00;A61P9/00;A61P11/00;A61P25/00;A61P29/00;A61P37/00;A61P37/08;A61P43/00;C07C237/22;C07D209/18;C07D209/20;C07D209/24;C07D223/12;C07D403/12;(IPC1-7):A61K31/40 主分类号 C07D223/10
代理机构 代理人
主权项
地址
您可能感兴趣的专利